Abstract
The aim of this study was to examine whether stimulation of β3-adrenoceptors dilates rat retinal blood vessels and how diabetes affects the vasodilator responses. Images of ocular fundus were captured with an original high-resolution digital fundus camera in vivo. The retinal vascular responses were evaluated by measuring diameter of retinal blood vessels contained in the digital images. Both systemic blood pressure and heart rate (HR) were continuously recorded. The β3-adrenoceptor agonist CL316243 (0.3–10 μg/kg/min, i.v.) increased diameter of retinal arterioles (at 10 μg/kg/min, a 31% increase) and decreased mean blood pressure (at 10 μg/kg/min, a 21% decrease) in a dose-dependent manner. CL316243 produced a small but significant increase in HR (at 10 μg/kg/min, a 9% increase). Both SR59230A (1 mg/kg, i.v.) and L-748337 (50 μg/kg, i.v.), β3-adrenoceptor antagonists, significantly prevented CL316243-induced retinal vasodilator responses. Similar observations were made with another β3-adrenoceptor agonist, BRL37344. The β2-adrenoceptor agonist salbutamol also increased diameter of retinal arterioles (at 10 μg/kg/min, a 43% increase), whereas the drug produced greater decrease in blood pressure (at 10 μg/kg/min, a 46% decrease) and increase in HR (at 10 μg/kg/min, a 16% increase), compared with β3-adrenoceptor agonists. The retinal vasodilator responses to CL316243 and BRL37344 observed under blockade of β1/β2-adrenoceptors with propranolol (2 mg/kg, i.v. bolus followed by 100 μg/kg/min infusion) were unaffected 2 weeks after induction of diabetes by the combination of streptozotocin treatment and d-glucose feeding. On the other hand, the vasodilator responses to salbutamol of retinal arterioles were significantly reduced in diabetic rats. These results suggest that stimulation of β3-adrenoceptors causes the vasodilation of retinal arterioles in vivo and the vasodilator responses are unaffected at the early stage of diabetes.
Similar content being viewed by others
References
Benedito S, Prieto D, Nielsen PJ, Nyborg NC (1991) Role of the endothelium in acetylcholine-induced relaxation and spontaneous tone of bovine isolated retinal small arteries. Exp Eye Res 52:575–579
Boussery K, Delaey C, Van de Voorde J (2002) Rat retinal tissue releases a vasorelaxing factor. Invest Ophthalmol Vis Sci 43:3279–3286
Candelore MR, Deng L, Tota L, Guan XM, Amend A, Liu Y, Newbold R, Cascieri MA, Weber AE (1999) Potent and selective human β3-adrenergic receptor antagonists. J Pharmacol Exp Ther 290:649–655
Chung S, Soh H, Uhm D (1999) β-Adrenergic modulation of maxi-K channels in vascular smooth muscle via Gi through a membrane-delimited pathway. Pflugers Arch 437:508–510
Delaey C, Van de Voorde J (1998) Retinal arterial tone is controlled by a retinal-derived relaxing factor. Circ Res 83:714–720
Delaey C, Van De Voorde J (2000) Regulatory mechanisms in the retinal and choroidal circulation. Ophthalmic Res 32:249–256
De La Cruz JP, Gonzalez-Correa JA, Guerrero A, de la Cuesta FS (2004) Pharmacological approach to diabetic retinopathy. Diabetes Metab Res Rev 20:91–113
Dincer UD, Bidasee KR, Guner S, Tay A, Ozcelikay AT, Altan VM (2001) The effect of diabetes on expression of β1-, β2-, and β3-adrenoreceptors in rat hearts. Diabetes 50:455–461
Dessy C, Moniotte S, Ghisdal P, Havaux X, Noirhomme P, Balligand JL (2004) Endothelial β3-adrenoceptors mediate vasorelaxation of human coronary microarteries through nitric oxide and endothelium-dependent hyperpolarization. Circulation 110:948–954
Feke GT, Buzney SM, Ogasawara H, Fujio N, Goger DG, Spack NP, Gabbay KH (1994) Retinal circulatory abnormalities in type 1 diabetes. Invest Ophthalmol Vis Sci 35:2968–2975
Flammer J, Orgul S, Costa VP, Orzalesi N, Krieglstein GK, Serra LM, Renard JP, Stefansson E (2002) The impact of ocular blood flow in glaucoma. Prog Retin Eye Res 21:359–393
Grieshaber MC, Flammer J (2005) Blood flow in glaucoma. Curr Opin Ophthalmol 16:79–83
Ghirlanda G, Di Leo MA, Caputo S, Cercone S, Greco AV (1997) From functional to microvascular abnormalities in early diabetic retinopathy. Diab Metab Rev 13:15–35
Haefliger IO, Flammer J, Luscher TF (1992) Nitric oxide and endothelin-1 are important regulators of human ophthalmic artery. Invest Ophthalmol Vis Sci 33:2340–2343
Mori A, Saigo O, Hanada M, Nakahara T, Ishii K (2009) Hyperglycemia accelerates impairment of vasodilator responses to acetylcholine of retinal blood vessels in rats. J Pharmacol Sci 110:160–168
Morimoto A, Hasegawa H, Cheng HJ, Little WC, Cheng CP (2004) Endogenous β3-adrenoreceptor activation contributes to left ventricular and cardiomyocyte dysfunction in heart failure. Am J Physiol Heart Circ Physiol 286:H2425–H2433
Nakazawa T, Kaneko Y, Mori A, Saito M, Sakamoto K, Nakahara T, Ishii K (2007) Attenuation of nitric oxide- and prostaglandin-independent vasodilation of retinal arterioles induced by acetylcholine in streptozotocin-treated rats. Vasc Pharmacol 46:153–159
Nakazawa T, Sato A, Mori A, Saito M, Sakamoto K, Nakahara T, Ishii K (2008) β-Adrenoceptor-mediated vasodilation of retinal blood vessels is reduced in streptozotocin-induced diabetic rats. Vasc Pharmacol 49:77–83
Oriowo MA (1994) Atypical β-adrenoceptors in the rat isolated common carotid artery. Br J Pharmacol 113:699–702
Pelat M, Verwaerde P, Galitzky J, Lafontan M, Berlan M, Senard JM, Montastruc JL (2003) High isoproterenol doses are required to activate β3-adrenoceptor-mediated functions in dogs. J Pharmacol Exp Ther 304:246–253
Rozec B, Gauthier C (2006) β3-Adrenoceptors in the cardiovascular system: putative roles in human pathologies. Pharmacol Ther 111:652–673
Sato M, Horinouchi T, Hutchinson DS, Evans BA, Summers RJ (2007) Ligand-directed signaling at the β3-adrenoceptor produced by 3-(2-ethylphenoxy)-1-[(1, S)-1, 2, 3, 4-tetrahydronapth-1-ylamino]-2S–2-propanol oxalate (SR59230A) relative to receptor agonists. Mol Pharmacol 72:1359–1368
Schmetterer L, Wolzt M (1999) Ocular blood flow and associated functional deviations in diabetic retinopathy. Diabetologia 42:387–405
Steinle JJ, Booz GW, Meininger CJ, Day JN, Granger HJ (2003) β3-Adrenergic receptors regulate retinal endothelial cell migration and proliferation. J Biol Chem 278:20681–20686
Trochu JN, Leblais V, Rautureau Y, Bévérelli F, Le Marec H, Berdeaux A, Gauthier C (1999) β3-Adrenoceptor stimulation induces vasorelaxation mediated essentially by endothelium-derived nitric oxide in rat thoracic aorta. Br J Pharmacol 128:69–76
Vrydag W, Michel MC (2007) Tools to study β3-adrenoceptors. Naunyn-Schmiedeberg’s Arch Pharmacol 374:385–398
Acknowledgments
This study was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (No. 20590090 T.N.; No. 21590102 K.I.); Suzuken Memorial Foundation (T.N.); and by a Kitasato University Research Grant for Young Researchers (A.M.).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mori, A., Miwa, T., Sakamoto, K. et al. Pharmacological evidence for the presence of functional β3-adrenoceptors in rat retinal blood vessels. Naunyn-Schmied Arch Pharmacol 382, 119–126 (2010). https://doi.org/10.1007/s00210-010-0526-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00210-010-0526-5